Aurigene Pharmaceutical Services introduces AI and machine learning assisted drug discovery platform
India, April 3 -- Aurigene Pharmaceutical Services, a contract research, development, and manufacturing services organisation and a Dr. Reddy's Laboratories company, has introduced Aurigene.AI, an artificial intelligence (AI) and machine learning (ML)-assisted platform for accelerating drug discovery projects from hit identification to candidate nomination.
Aurigene.AI combines advanced physics-based simulation, generative and predictive AI models, and CADD (Computer-Aided Drug Design) in one platform, allowing users to pick the appropriate algorithms for a given application. The modular platform also consists of a meticulously curated database of 180 million compounds and 1.6 million validated bioassay data points. This database is ever...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.